on 11 Feb 2020
Last Applicant/ Owned by
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
Serial Number
88461039 filed on 05th Jun 2019
Registration Number
5981450 registered on 11th Feb 2020
Correspondent Address
Michael J. Leonard Fox Rothschild LLP
Filing Basis
1. intent to use
Disclaimer
NO DATA
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological reRead More
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies
11th 000101
11th 000101
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
11th 000101
11th 000101
No 88461039
No Service Mark
No 114353.00089
Yes
No
No
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st May 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 24th Apr 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 11th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
| 26th Nov 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Nov 2019 | PUBLISHED FOR OPPOSITION |
| 06th Nov 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Oct 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| 11th Oct 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 07th Oct 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 13th Sep 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
